{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:23:23Z","timestamp":1782221003646,"version":"3.54.5"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5R01DK098135, 5R01DK094987"],"award-info":[{"award-number":["5R01DK098135, 5R01DK094987"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Duke Pediatric Research Scholar (DPRS) program","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00467-018-4093-1","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T13:16:10Z","timestamp":1538486170000},"page":"2279-2293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of steroid-resistant nephrotic syndrome in the genomic era"],"prefix":"10.1007","volume":"34","author":[{"given":"Adam R.","family":"Bensimhon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5641-6644","authenticated-orcid":false,"given":"Rasheed A.","family":"Gbadegesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"key":"4093_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639","journal-title":"Lancet"},{"key":"4093_CR2","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"16","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 16:1040\u20131044","journal-title":"Pediatr Nephrol"},{"key":"4093_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"DC Cattran","year":"2012","unstructured":"Cattran DC, Feehally J, Cook T, Liu ZH, Fervenza FC, Mezzano SA, Floege J, Nachman PH, Gipson DS, Praga M, Glassock RJ, Radhakrishnan J, Hodson EM, Rovin BH, Jha V, Troyanov S, Li PKT, Wetzels JFM (2012) Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Intl Suppl 2:139\u2013274","journal-title":"Kidney Intl Suppl"},{"key":"4093_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF01956754","volume":"152","author":"JH Ehrich","year":"1993","unstructured":"Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 152:357\u2013361","journal-title":"Eur J Pediatr"},{"key":"4093_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","volume":"98","author":"Children ISoKDi","year":"1981","unstructured":"Children ISoKDi (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561\u2013564","journal-title":"J Pediatr"},{"key":"4093_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1399-3046.2007.00704.x","volume":"11","author":"JM Smith","year":"2007","unstructured":"Smith JM, Stablein DM, Munoz R, Hebert D, McDonald RA (2007) Contributions of the transplant registry: the 2006 annual report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant 11:366\u2013373","journal-title":"Pediatr Transplant"},{"key":"4093_CR7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","volume":"375","author":"F Hildebrandt","year":"2010","unstructured":"Hildebrandt F (2010) Genetic kidney diseases. Lancet 375:1287\u20131295","journal-title":"Lancet"},{"key":"4093_CR8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","volume":"71","author":"RC Wiggins","year":"2007","unstructured":"Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71:1205\u20131214","journal-title":"Kidney Int"},{"key":"4093_CR9","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.2014050489","volume":"26","author":"CE Sadowski","year":"2015","unstructured":"Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA, Group SS, Hildebrandt F (2015) A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 26:1279\u20131289","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2215\/CJN.09010813","volume":"9","author":"S Lovric","year":"2014","unstructured":"Lovric S, Fang H, Vega-Warner V, Sadowski CE, Gee HY, Halbritter J, Ashraf S, Saisawat P, Soliman NA, Kari JA, Otto EA, Hildebrandt F, Nephrotic Syndrome Study Group (2014) Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 9:1109\u20131116","journal-title":"Clin J Am Soc Nephrol"},{"key":"4093_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Ozkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Ozcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium (2015) Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol 10:592\u2013600","journal-title":"Clin J Am Soc Nephrol"},{"key":"4093_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","volume":"91","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska A, McCarthy HJ, Soderquest K, Sen ES, Colby E, Ding WY, Nabhan MM, Kerecuk L, Hegde S, Hughes D, Marks S, Feather S, Jones C, Webb NJ, Ognjanovic M, Christian M, Gilbert RD, Sinha MD, Lord GM, Simpson M, Koziell AB, Welsh GI, Saleem MA (2017) Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int 91:937\u2013947","journal-title":"Kidney Int"},{"key":"4093_CR13","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1681\/ASN.2015050504","volume":"27","author":"MG Sampson","year":"2016","unstructured":"Sampson MG, Gillies CE, Robertson CC, Crawford B, Vega-Warner V, Otto EA, Kretzler M, Kang HM (2016) Using population genetics to interrogate the monogenic nephrotic syndrome diagnosis in a case cohort. J Am Soc Nephrol 27:1970\u20131983","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2215\/CJN.07370715","volume":"11","author":"AK Buscher","year":"2016","unstructured":"Buscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tonshoff B, Hoyer PF, Konrad M, Weber S, German Pediatric Nephrology Association (GPN) (2016) Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 11:245\u2013253","journal-title":"Clin J Am Soc Nephrol"},{"key":"4093_CR15","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1681\/ASN.2016101121","volume":"28","author":"A Trautmann","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zietkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F, PodoNet Consortium (2017) Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol 28:3055\u20133065","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.krcp.2012.04.323","volume":"31","author":"WY Ding","year":"2012","unstructured":"Ding WY, Saleem MA (2012) Current concepts of the podocyte in nephrotic syndrome. Kidney Res Clin Pract 31:87\u201393","journal-title":"Kidney Res Clin Pract"},{"key":"4093_CR17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14:931\u2013938","journal-title":"Nat Med"},{"key":"4093_CR18","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1074\/jbc.M116.755546","volume":"292","author":"X Zhao","year":"2017","unstructured":"Zhao X, Khurana S, Charkraborty S, Tian Y, Sedor JR, Bruggman LA, Kao HY (2017) Alpha actinin 4 (ACTN4) regulates glucocorticoid receptor-mediated transactivation and transrepression in podocytes. J Biol Chem 292:1637\u20131647","journal-title":"J Biol Chem"},{"key":"4093_CR19","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1681\/ASN.2013090976","volume":"25","author":"RA Gbadegesin","year":"2014","unstructured":"Gbadegesin RA, Hall G, Adeyemo A, Hanke N, Tossidou I, Burchette J, Wu G, Homstad A, Sparks MA, Gomez J, Jiang R, Alonso A, Lavin P, Conlon P, Korstanje R, Stander MC, Shamsan G, Barua M, Spurney R, Singhal PC, Kopp JB, Haller H, Howell D, Pollak MR, Shaw AS, Schiffer M, Winn MP (2014) Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS. J Am Soc Nephrol 25:1991\u20132002","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"VD D\u2019Agati","year":"2004","unstructured":"D\u2019Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 43:368\u2013382","journal-title":"Am J Kidney Dis"},{"key":"4093_CR21","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","volume":"365","author":"VD D\u2019Agati","year":"2011","unstructured":"D\u2019Agati VD, Kaskel FJ, Falk RJ (2011) Focal segmental glomerulosclerosis. N Engl J Med 365:2398\u20132411","journal-title":"N Engl J Med"},{"key":"4093_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo AB (2015) Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol 11:76\u201387","journal-title":"Nat Rev Nephrol"},{"key":"4093_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00431-011-1668-2","volume":"171","author":"AK Buscher","year":"2012","unstructured":"Buscher AK, Weber S (2012) Educational paper: the podocytopathies. Eur J Pediatr 171:1151\u20131160","journal-title":"Eur J Pediatr"},{"key":"4093_CR24","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1056\/NEJMra052131","volume":"354","author":"K Tryggvason","year":"2006","unstructured":"Tryggvason K, Patrakka J, Wartiovaara J (2006) Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354:1387\u20131401","journal-title":"N Engl J Med"},{"key":"4093_CR25","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00467-016-3456-8","volume":"32","author":"AM Karp","year":"2017","unstructured":"Karp AM, Gbadegesin RA (2017) Genetics of childhood steroid-sensitive nephrotic syndrome. Pediatr Nephrol 32:1481\u20131488","journal-title":"Pediatr Nephrol"},{"key":"4093_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556\u2013560","journal-title":"Lancet"},{"key":"4093_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2004030172","volume":"16","author":"RJ Coward","year":"2005","unstructured":"Coward RJ, Foster RR, Patton D, Ni L, Lennon R, Bates DO, Harper SJ, Mathieson PW, Saleem MA (2005) Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR28","first-page":"32","volume":"22","author":"SW Zimmerman","year":"1984","unstructured":"Zimmerman SW (1984) Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 22:32\u201338","journal-title":"Clin Nephrol"},{"key":"4093_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","volume":"31","author":"JC Davin","year":"2016","unstructured":"Davin JC (2016) The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr Nephrol 31:207\u2013215","journal-title":"Pediatr Nephrol"},{"key":"4093_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.7326\/0003-4819-81-4-440","volume":"81","author":"JR Weisinger","year":"1974","unstructured":"Weisinger JR, Kempson RL, Eldridge FL, Swenson RS (1974) The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 81:440\u2013447","journal-title":"Ann Intern Med"},{"key":"4093_CR31","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","volume":"59","author":"N Kambham","year":"2001","unstructured":"Kambham N, Markowitz GS, Valeri AM, Lin J, D\u2019Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498\u20131509","journal-title":"Kidney Int"},{"key":"4093_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0272-6386(85)80113-X","volume":"5","author":"DB Bhathena","year":"1985","unstructured":"Bhathena DB, Julian BA, McMorrow RG, Baehler RW (1985) Focal sclerosis of hypertrophied glomeruli in solitary functioning kidneys of humans. Am J Kidney Dis 5:226\u2013232","journal-title":"Am J Kidney Dis"},{"key":"4093_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1440-1754.2008.01315.x","volume":"44","author":"MF Schreuder","year":"2008","unstructured":"Schreuder MF, Langemeijer ME, Bokenkamp A, Delemarre-Van de Waal HA, Van Wijk JA (2008) Hypertension and microalbuminuria in children with congenital solitary kidneys. J Paediatr Child Health 44:363\u2013368","journal-title":"J Paediatr Child Health"},{"key":"4093_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrneph.2012.286","volume":"9","author":"RA Gbadegesin","year":"2013","unstructured":"Gbadegesin RA, Winn MP, Smoyer WE (2013) Genetic testing in nephrotic syndrome\u2014challenges and opportunities. Nat Rev Nephrol 9:179\u2013184","journal-title":"Nat Rev Nephrol"},{"key":"4093_CR35","first-page":"226","volume":"5","author":"A Bierzynska","year":"2014","unstructured":"Bierzynska A, Soderquest K, Koziell A (2014) Genes and podocytes\u2014new insights into mechanisms of podocytopathy. Front Endocrinol (Lausanne) 5:226","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4093_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ajhg.2014.11.014","volume":"96","author":"L Ebarasi","year":"2015","unstructured":"Ebarasi L, Ashraf S, Bierzynska A, Gee HY, McCarthy HJ, Lovric S, Sadowski CE, Pabst W, Vega-Warner V, Fang H, Koziell A, Simpson MA, Dursun I, Serdaroglu E, Levy S, Saleem MA, Hildebrandt F, Majumdar A (2015) Defects of CRB2 cause steroid-resistant nephrotic syndrome. Am J Hum Genet 96:153\u2013161","journal-title":"Am J Hum Genet"},{"key":"4093_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ajhg.2015.08.013","volume":"97","author":"N Miyake","year":"2015","unstructured":"Miyake N, Tsukaguchi H, Koshimizu E, Shono A, Matsunaga S, Shiina M, Mimura Y, Imamura S, Hirose T, Okudela K, Nozu K, Akioka Y, Hattori M, Yoshikawa N, Kitamura A, Cheong HI, Kagami S, Yamashita M, Fujita A, Miyatake S, Tsurusaki Y, Nakashima M, Saitsu H, Ohashi K, Imamoto N, Ryo A, Ogata K, Iijima K, Matsumoto N (2015) Biallelic mutations in nuclear pore complex subunit NUP107 cause early-childhood-onset steroid-resistant nephrotic syndrome. Am J Hum Genet 97:555\u2013566","journal-title":"Am J Hum Genet"},{"key":"4093_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.3512","volume":"48","author":"DA Braun","year":"2016","unstructured":"Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, Gee HY, Ashraf S, Lawson JA, Shril S, Airik M, Tan W, Schapiro D, Rao J, Choi WI, Hermle T, Kemper MJ, Pohl M, Ozaltin F, Konrad M, Bogdanovic R, Buscher R, Helmchen U, Serdaroglu E, Lifton RP, Antonin W, Hildebrandt F (2016) Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. Nat Genet 48:457\u2013465","journal-title":"Nat Genet"},{"key":"4093_CR39","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1172\/JCI79504","volume":"125","author":"HY Gee","year":"2015","unstructured":"Gee HY, Zhang F, Ashraf S, Kohl S, Sadowski CE, Vega-Warner V, Zhou W, Lovric S, Fang H, Nettleton M, Zhu JY, Hoefele J, Weber LT, Podracka L, Boor A, Fehrenbach H, Innis JW, Washburn J, Levy S, Lifton RP, Otto EA, Han Z, Hildebrandt F (2015) KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J Clin Invest 125:2375\u20132384","journal-title":"J Clin Invest"},{"key":"4093_CR40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2215\/CJN.07200712","volume":"8","author":"HJ McCarthy","year":"2013","unstructured":"McCarthy HJ, Bierzynska A, Wherlock M, Ognjanovic M, Kerecuk L, Hegde S, Feather S, Gilbert RD, Krischock L, Jones C, Sinha MD, Webb NJ, Christian M, Williams MM, Marks S, Koziell A, Welsh GI, Saleem MA, RADAR the UK SRNS Study Group (2013) Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 8:637\u2013648","journal-title":"Clin J Am Soc Nephrol"},{"key":"4093_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2215\/CJN.04120417","volume":"13","author":"JK Warejko","year":"2018","unstructured":"Warejko JK, Tan W, Daga A, Schapiro D, Lawson JA, Shril S, Lovric S, Ashraf S, Rao J, Hermle T, Jobst-Schwan T, Widmeier E, Majmundar AJ, Schneider R, Gee HY, Schmidt JM, Vivante A, van der Ven AT, Ityel H, Chen J, Sadowski CE, Kohl S, Pabst WL, Nakayama M, Somers MJG, Rodig NM, Daouk G, Baum M, Stein DR, Ferguson MA, Traum AZ, Soliman NA, Kari JA, El Desoky S, Fathy H, Zenker M, Bakkaloglu SA, Muller D, Noyan A, Ozaltin F, Cadnapaphornchai MA, Hashmi S, Hopcian J, Kopp JB, Benador N, Bockenhauer D, Bogdanovic R, Stajic N, Chernin G, Ettenger R, Fehrenbach H, Kemper M, Munarriz RL, Podracka L, Buscher R, Serdaroglu E, Tasic V, Mane S, Lifton RP, Braun DA, Hildebrandt F (2018) Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 13:53\u201362","journal-title":"Clin J Am Soc Nephrol"},{"key":"4093_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ki.2011.297","volume":"81","author":"RA Gbadegesin","year":"2012","unstructured":"Gbadegesin RA, Lavin PJ, Hall G, Bartkowiak B, Homstad A, Jiang R, Wu G, Byrd A, Lynn K, Wolfish N, Ottati C, Stevens P, Howell D, Conlon P, Winn MP (2012) Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis. Kidney Int 81:94\u201399","journal-title":"Kidney Int"},{"key":"4093_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ng.505","volume":"42","author":"EJ Brown","year":"2010","unstructured":"Brown EJ, Schlondorff JS, Becker DJ, Tsukaguchi H, Tonna SJ, Uscinski AL, Higgs HN, Henderson JM, Pollak MR (2010) Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet 42:72\u201376","journal-title":"Nat Genet"},{"key":"4093_CR44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ki.2012.349","volume":"83","author":"M Barua","year":"2013","unstructured":"Barua M, Brown EJ, Charoonratana VT, Genovese G, Sun H, Pollak MR (2013) Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney Int 83:316\u2013322","journal-title":"Kidney Int"},{"key":"4093_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1681\/ASN.2010050518","volume":"22","author":"O Boyer","year":"2011","unstructured":"Boyer O, Benoit G, Gribouval O, Nevo F, Tete MJ, Dantal J, Gilbert-Dussardier B, Touchard G, Karras A, Presne C, Grunfeld JP, Legendre C, Joly D, Rieu P, Mohsin N, Hannedouche T, Moal V, Gubler MC, Broutin I, Mollet G, Antignac C (2011) Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. J Am Soc Nephrol 22:239\u2013245","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR46","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ki.2014.305","volume":"86","author":"AF Malone","year":"2014","unstructured":"Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA (2014) Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86:1253\u20131259","journal-title":"Kidney Int"},{"key":"4093_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/ki.2013.93","volume":"84","author":"BS Lipska","year":"2013","unstructured":"Lipska BS, Iatropoulos P, Maranta R, Caridi G, Ozaltin F, Anarat A, Balat A, Gellermann J, Trautmann A, Erdogan O, Saeed B, Emre S, Bogdanovic R, Azocar M, Balasz-Chmielewska I, Benetti E, Caliskan S, Mir S, Melk A, Ertan P, Baskin E, Jardim H, Davitaia T, Wasilewska A, Drozdz D, Szczepanska M, Jankauskiene A, Higuita LM, Ardissino G, Ozkaya O, Kuzma-Mroczkowska E, Soylemezoglu O, Ranchin B, Medynska A, Tkaczyk M, Peco-Antic A, Akil I, Jarmolinski T, Firszt-Adamczyk A, Dusek J, Simonetti GD, Gok F, Gheissari A, Emma F, Krmar RT, Fischbach M, Printza N, Simkova E, Mele C, Ghiggeri GM, Schaefer F, PodoNet Consortium (2013) Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int 84:206\u2013213","journal-title":"Kidney Int"},{"key":"4093_CR48","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1542\/peds.2006-2164","volume":"119","author":"BG Hinkes","year":"2007","unstructured":"Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, Arbeitsgemeinschaft fur Paediatrische Nephrologie Study Group (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907\u2013e919","journal-title":"Pediatrics"},{"key":"4093_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1681\/ASN.2007040452","volume":"19","author":"B Hinkes","year":"2008","unstructured":"Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J, Hasselbacher K, Ozaltin F, Hildebrandt F, APN Study Group (2008) Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 19:365\u2013371","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR50","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/ndt\/gfm759","volume":"23","author":"R Gbadegesin","year":"2008","unstructured":"Gbadegesin R, Hinkes BG, Hoskins BE, Vlangos CN, Heeringa SF, Liu J, Loirat C, Ozaltin F, Hashmi S, Ulmer F, Cleper R, Ettenger R, Antignac C, Wiggins RC, Zenker M, Hildebrandt F (2008) Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 23:1291\u20131297","journal-title":"Nephrol Dial Transplant"},{"key":"4093_CR51","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/01.ASN.0000118135.00519.B0","volume":"15","author":"P Niaudet","year":"2004","unstructured":"Niaudet P (2004) Podocin and nephrotic syndrome: implications for the clinician. J Am Soc Nephrol 15:832\u2013834","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR52","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1681\/ASN.2013080852","volume":"25","author":"WY Ding","year":"2014","unstructured":"Ding WY, Koziell A, McCarthy HJ, Bierzynska A, Bhagavatula MK, Dudley JA, Inward CD, Coward RJ, Tizard J, Reid C, Antignac C, Boyer O, Saleem MA (2014) Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol 25:1342\u20131348","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR53","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841\u2013845","journal-title":"Science"},{"key":"4093_CR54","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1681\/ASN.2010070730","volume":"21","author":"BI Freedman","year":"2010","unstructured":"Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, Winkler CA, Bowden DW, Pollak MR (2010) The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 21:1422\u20131426","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/ng.792","volume":"43","author":"K Okamoto","year":"2011","unstructured":"Okamoto K, Tokunaga K, Doi K, Fujita T, Suzuki H, Katoh T, Watanabe T, Nishida N, Mabuchi A, Takahashi A, Kubo M, Maeda S, Nakamura Y, Noiri E (2011) Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat Genet 43:459\u2013463","journal-title":"Nat Genet"},{"key":"4093_CR56","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","volume":"15","author":"RG Ruf","year":"2004","unstructured":"Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F, Arbeitsgemeinschaft Fur Padiatrische Nephrologie Study Group (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15:722\u2013732","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR57","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1172\/JCI45693","volume":"121","author":"SF Heeringa","year":"2011","unstructured":"Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z, Xie LX, Salviati L, Hurd TW, Vega-Warner V, Killen PD, Raphael Y, Ashraf S, Ovunc B, Schoeb DS, McLaughlin HM, Airik R, Vlangos CN, Gbadegesin R, Hinkes B, Saisawat P, Trevisson E, Doimo M, Casarin A, Pertegato V, Giorgi G, Prokisch H, Rotig A, Nurnberg G, Becker C, Wang S, Ozaltin F, Topaloglu R, Bakkaloglu A, Bakkaloglu SA, Muller D, Beissert A, Mir S, Berdeli A, Varpizen S, Zenker M, Matejas V, Santos-Ocana C, Navas P, Kusakabe T, Kispert A, Akman S, Soliman NA, Krick S, Mundel P, Reiser J, Nurnberg P, Clarke CF, Wiggins RC, Faul C, Hildebrandt F (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013\u20132024","journal-title":"J Clin Invest"},{"key":"4093_CR58","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1523-1755.2004.00776.x","volume":"66","author":"S Weber","year":"2004","unstructured":"Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete MJ, Legendre C, Niaudet P, Antignac C (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66:571\u2013579","journal-title":"Kidney Int"},{"key":"4093_CR59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/pd.1171","volume":"25","author":"M Gigante","year":"2005","unstructured":"Gigante M, Greco P, Defazio V, Lucci M, Margaglione M, Gesualdo L, Iolascon A (2005) Congenital nephrotic syndrome of Finnish type: detection of new nephrin mutations and prenatal diagnosis in an Italian family. Prenat Diagn 25:407\u2013410","journal-title":"Prenat Diagn"},{"key":"4093_CR60","doi-asserted-by":"crossref","unstructured":"(1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A report of the International Study of Kidney Disease in Children. Kidney Int 20:765\u2013771","DOI":"10.1038\/ki.1981.209"},{"key":"4093_CR61","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","volume":"3","author":"DA Black","year":"1970","unstructured":"Black DA, Rose G, Brewer DB (1970) Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J 3:421\u2013426","journal-title":"Br Med J"},{"key":"4093_CR62","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/0272-6386(95)90120-5","volume":"25","author":"JJ Rydel","year":"1995","unstructured":"Rydel JJ, Korbet SM, Borok RZ, Schwartz MM (1995) Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 25:534\u2013542","journal-title":"Am J Kidney Dis"},{"key":"4093_CR63","first-page":"53","volume":"36","author":"G Banfi","year":"1991","unstructured":"Banfi G, Moriggi M, Sabadini E, Fellin G, D\u2019Amico G, Ponticelli C (1991) The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36:53\u201359","journal-title":"Clin Nephrol"},{"key":"4093_CR64","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","volume":"23","author":"SM Korbet","year":"1994","unstructured":"Korbet SM, Schwartz MM, Lewis EJ (1994) Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 23:773\u2013783","journal-title":"Am J Kidney Dis"},{"key":"4093_CR65","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","volume":"70","author":"CY Xing","year":"2006","unstructured":"Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW (2006) Direct effects of dexamethasone on human podocytes. Kidney Int 70:1038\u20131045","journal-title":"Kidney Int"},{"key":"4093_CR66","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/j.1523-1755.2005.00723.x","volume":"68","author":"RF Ransom","year":"2005","unstructured":"Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE (2005) Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 68:2473\u20132483","journal-title":"Kidney Int"},{"key":"4093_CR67","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1681\/ASN.2005020142","volume":"16","author":"T Wada","year":"2005","unstructured":"Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ (2005) Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16:2615\u20132625","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1681\/ASN.2015060672","volume":"28","author":"SK Mallipattu","year":"2017","unstructured":"Mallipattu SK, Guo Y, Revelo MP, Roa-Pena L, Miller T, Ling J, Shankland SJ, Bialkowska AB, Ly V, Estrada C, Jain MK, Lu Y, Ma\u2019ayan A, Mehrotra A, Yacoub R, Nord EP, Woroniecki RP, Yang VW, He JC (2017) Kruppel-like factor 15 mediates glucocorticoid-induced restoration of podocyte differentiation markers. J Am Soc Nephrol 28:166\u2013184","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR69","doi-asserted-by":"publisher","first-page":"19122","DOI":"10.1074\/jbc.M112.345983","volume":"287","author":"SK Mallipattu","year":"2012","unstructured":"Mallipattu SK, Liu R, Zheng F, Narla G, Ma\u2019ayan A, Dikman S, Jain MK, Saleem M, D\u2019Agati V, Klotman P, Chuang PY, He JC (2012) Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem 287:19122\u201319135","journal-title":"J Biol Chem"},{"key":"4093_CR70","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/ng1918","volume":"38","author":"B Hinkes","year":"2006","unstructured":"Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Soylu A, Muller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O\u2019Toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nurnberg P, Hildebrandt F (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38:1397\u20131405","journal-title":"Nat Genet"},{"key":"4093_CR71","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ajhg.2014.04.010","volume":"94","author":"HY Gee","year":"2014","unstructured":"Gee HY, Ashraf S, Wan X, Vega-Warner V, Esteve-Rudd J, Lovric S, Fang H, Hurd TW, Sadowski CE, Allen SJ, Otto EA, Korkmaz E, Washburn J, Levy S, Williams DS, Bakkaloglu SA, Zolotnitskaya A, Ozaltin F, Zhou W, Hildebrandt F (2014) Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am J Hum Genet 94:884\u2013890","journal-title":"Am J Hum Genet"},{"key":"4093_CR72","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1038\/s41467-018-04193-w","volume":"9","author":"S Ashraf","year":"2018","unstructured":"Ashraf S, Kudo H, Rao J, Kikuchi A, Widmeier E, Lawson JA, Tan W, Hermle T, Warejko JK, Shril S, Airik M, Jobst-Schwan T, Lovric S, Braun DA, Gee HY, Schapiro D, Majmundar AJ, Sadowski CE, Pabst WL, Daga A, van der Ven AT, Schmidt JM, Low BC, Gupta AB, Tripathi BK, Wong J, Campbell K, Metcalfe K, Schanze D, Niihori T, Kaito H, Nozu K, Tsukaguchi H, Tanaka R, Hamahira K, Kobayashi Y, Takizawa T, Funayama R, Nakayama K, Aoki Y, Kumagai N, Iijima K, Fehrenbach H, Kari JA, El Desoky S, Jalalah S, Bogdanovic R, Stajic N, Zappel H, Rakhmetova A, Wassmer SR, Jungraithmayr T, Strehlau J, Kumar AS, Bagga A, Soliman NA, Mane SM, Kaufman L, Lowy DR, Jairajpuri MA, Lifton RP, Pei Y, Zenker M, Kure S, Hildebrandt F (2018) Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat Commun 9:1960","journal-title":"Nat Commun"},{"key":"4093_CR73","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/352803a0","volume":"352","author":"WM Flanagan","year":"1991","unstructured":"Flanagan WM, Corthesy B, Bram RJ, Crabtree GR (1991) Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352:803\u2013807","journal-title":"Nature"},{"key":"4093_CR74","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1128\/MCB.13.8.4760","volume":"13","author":"RJ Bram","year":"1993","unstructured":"Bram RJ, Hung DT, Martin PK, Schreiber SL, Crabtree GR (1993) Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol 13:4760\u20134769","journal-title":"Mol Cell Biol"},{"key":"4093_CR75","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/357692a0","volume":"357","author":"SJ O\u2019Keefe","year":"1992","unstructured":"O\u2019Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O\u2019Neill EA (1992) FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357:692\u2013694","journal-title":"Nature"},{"key":"4093_CR76","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/357695a0","volume":"357","author":"NA Clipstone","year":"1992","unstructured":"Clipstone NA, Crabtree GR (1992) Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695\u2013697","journal-title":"Nature"},{"key":"4093_CR77","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/ki.2011.195","volume":"80","author":"DS Gipson","year":"2011","unstructured":"Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D\u2019Agati VD, Friedman AL (2011) Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 80:868\u2013878","journal-title":"Kidney Int"},{"key":"4093_CR78","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1177\/1535370214530365","volume":"239","author":"X Li","year":"2014","unstructured":"Li X, Zhang X, Li X, Wang X, Wang S, Ding J (2014) Cyclosporine A protects podocytes via stabilization of cofilin-1 expression in the unphosphorylated state. Exp Biol Med (Maywood) 239:922\u2013936","journal-title":"Exp Biol Med (Maywood)"},{"key":"4093_CR79","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2215\/CJN.01190210","volume":"5","author":"AK Buscher","year":"2010","unstructured":"Buscher AK, Kranz B, Buscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Broking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M (2010) Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 5:2075\u20132084","journal-title":"Clin J Am Soc Nephrol"},{"key":"4093_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1681\/ASN.2013111155","volume":"26","author":"S Giglio","year":"2015","unstructured":"Giglio S, Provenzano A, Mazzinghi B, Becherucci F, Giunti L, Sansavini G, Ravaglia F, Roperto RM, Farsetti S, Benetti E, Rotondi M, Murer L, Lazzeri E, Lasagni L, Materassi M, Romagnani P (2015) Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol 26:230\u2013236","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR81","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00467-015-3109-3","volume":"30","author":"I Klaassen","year":"2015","unstructured":"Klaassen I, Ozgoren B, Sadowski CE, Moller K, van Husen M, Lehnhardt A, Timmermann K, Freudenberg F, Helmchen U, Oh J, Kemper MJ (2015) Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible. Pediatr Nephrol 30:1477\u20131483","journal-title":"Pediatr Nephrol"},{"key":"4093_CR82","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00431-011-1397-6","volume":"170","author":"CJ Stefanidis","year":"2011","unstructured":"Stefanidis CJ, Querfeld U (2011) The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations. Eur J Pediatr 170:1377\u20131383","journal-title":"Eur J Pediatr"},{"key":"4093_CR83","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00467-010-1468-3","volume":"25","author":"J Gellermann","year":"2010","unstructured":"Gellermann J, Stefanidis CJ, Mitsioni A, Querfeld U (2010) Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol 25:1285\u20131289","journal-title":"Pediatr Nephrol"},{"key":"4093_CR84","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00431-010-1278-4","volume":"170","author":"AM Wasilewska","year":"2011","unstructured":"Wasilewska AM, Kuroczycka-Saniutycz E, Zoch-Zwierz W (2011) Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr 170:389\u2013391","journal-title":"Eur J Pediatr"},{"key":"4093_CR85","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/gtmb.2008.0083","volume":"13","author":"S Megremis","year":"2009","unstructured":"Megremis S, Mitsioni A, Mitsioni AG, Fylaktou I, Kitsiou-Tzelli S, Stefanidis CJ, Kanavakis E, Traeger-Synodinos J (2009) Nucleotide variations in the NPHS2 gene in Greek children with steroid-resistant nephrotic syndrome. Genet Test Mol Biomarkers 13:249\u2013256","journal-title":"Genet Test Mol Biomarkers"},{"key":"4093_CR86","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00467-009-1211-0","volume":"24","author":"M Malina","year":"2009","unstructured":"Malina M, Cinek O, Janda J, Seeman T (2009) Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation. Pediatr Nephrol 24:2051\u20132053","journal-title":"Pediatr Nephrol"},{"key":"4093_CR87","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5301\/JN.2011.6327","volume":"24","author":"TT Gargah","year":"2011","unstructured":"Gargah TT, Lakhoua MR (2011) Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome. J Nephrol 24:203\u2013207","journal-title":"J Nephrol"},{"key":"4093_CR88","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00467-009-1356-x","volume":"25","author":"VR de Mello","year":"2010","unstructured":"de Mello VR, Rodrigues MT, Mastrocinque TH, Martins SP, de Andrade OV, Guidoni EB, Scheffer DK, Martini Filho D, Toporovski J, Benini V (2010) Mycophenolate mofetil in children with steroid\/cyclophosphamide-resistant nephrotic syndrome. Pediatr Nephrol 25:453\u2013460","journal-title":"Pediatr Nephrol"},{"key":"4093_CR89","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.V9112055","volume":"9","author":"R Ziswiler","year":"1998","unstructured":"Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP (1998) Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9:2055\u20132066","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR90","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/ndt\/14.1.58","volume":"14","author":"IA Hauser","year":"1999","unstructured":"Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M (1999) Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 14:58\u201363","journal-title":"Nephrol Dial Transplant"},{"key":"4093_CR91","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V9122272","volume":"9","author":"MJ Penny","year":"1998","unstructured":"Penny MJ, Boyd RA, Hall BM (1998) Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition. J Am Soc Nephrol 9:2272\u20132282","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR92","first-page":"67","volume":"25","author":"AC Allison","year":"1993","unstructured":"Allison AC, Kowalski WJ, Muller CJ, Waters RV, Eugui EM (1993) Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant Proc 25:67\u201370","journal-title":"Transplant Proc"},{"key":"4093_CR93","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5414\/CNP62405","volume":"62","author":"DC Cattran","year":"2004","unstructured":"Cattran DC, Wang MM, Appel G, Matalon A, Briggs W (2004) Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol 62:405\u2013411","journal-title":"Clin Nephrol"},{"key":"4093_CR94","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00467-003-1174-5","volume":"18","author":"B Montane","year":"2003","unstructured":"Montane B, Abitbol C, Chandar J, Strauss J, Zilleruelo G (2003) Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade. Pediatr Nephrol 18:772\u2013777","journal-title":"Pediatr Nephrol"},{"key":"4093_CR95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ncpneph0133","volume":"2","author":"AD Salama","year":"2006","unstructured":"Salama AD, Pusey CD (2006) Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2:221\u2013230","journal-title":"Nat Clin Pract Nephrol"},{"key":"4093_CR96","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212","journal-title":"Clin J Am Soc Nephrol"},{"key":"4093_CR97","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00467-009-1376-6","volume":"25","author":"A Prytula","year":"2010","unstructured":"Prytula A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, Taylor M, Marks SD, Tuchman S, Camilla R, Ognjanovic M, Filler G, Smith G, Tullus K (2010) Rituximab in refractory nephrotic syndrome. Pediatr Nephrol 25:461\u2013468","journal-title":"Pediatr Nephrol"},{"key":"4093_CR98","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00467-012-2319-1","volume":"28","author":"S Ito","year":"2013","unstructured":"Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K (2013) Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Pediatr Nephrol 28:257\u2013264","journal-title":"Pediatr Nephrol"},{"key":"4093_CR99","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751\u20132752","journal-title":"N Engl J Med"},{"key":"4093_CR100","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1681\/ASN.2011080775","volume":"23","author":"A Magnasco","year":"2012","unstructured":"Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri GM (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117\u20131124","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR101","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-014-2765-z","volume":"29","author":"K Kamei","year":"2014","unstructured":"Kamei K, Okada M, Sato M, Fujimaru T, Ogura M, Nakayama M, Kaito H, Iijima K, Ito S (2014) Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol 29:1181\u20131187","journal-title":"Pediatr Nephrol"},{"key":"4093_CR102","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85ra46","journal-title":"Sci Transl Med"},{"key":"4093_CR103","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1152\/ajprenal.00683.2014","volume":"309","author":"G Hall","year":"2015","unstructured":"Hall G, Gbadegesin RA (2015) Translating genetic findings in hereditary nephrotic syndrome: the missing loops. Am J Physiol Renal Physiol 309:F24\u2013F28","journal-title":"Am J Physiol Renal Physiol"},{"key":"4093_CR104","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","volume":"1660","author":"M Turunen","year":"2004","unstructured":"Turunen M, Olsson J, Dallner G (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660:171\u2013199","journal-title":"Biochim Biophys Acta"},{"key":"4093_CR105","unstructured":"Tran UC, Clarke CF (2007) Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion (7 Suppl):S62\u2013S71"},{"key":"4093_CR106","doi-asserted-by":"crossref","unstructured":"Crane FL (2007) Discovery of ubiquinone (coenzyme Q) and an overview of function. Mitochondrion (7 Suppl):S2\u2013S7","DOI":"10.1016\/j.mito.2007.02.011"},{"key":"4093_CR107","doi-asserted-by":"crossref","unstructured":"Bentinger M, Brismar K, Dallner G (2007) The antioxidant role of coenzyme Q. Mitochondrion (7 Suppl):S41\u2013S50","DOI":"10.1016\/j.mito.2007.02.006"},{"key":"4093_CR108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000362826","volume":"5","author":"M Doimo","year":"2014","unstructured":"Doimo M, Desbats MA, Cerqua C, Cassina M, Trevisson E, Salviati L (2014) Genetics of coenzyme q10 deficiency. Mol Syndromol 5:156\u2013162","journal-title":"Mol Syndromol"},{"key":"4093_CR109","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/ejhg.2014.277","volume":"23","author":"MA Desbats","year":"2015","unstructured":"Desbats MA, Vetro A, Limongelli I, Lunardi G, Casarin A, Doimo M, Spinazzi M, Angelini C, Cenacchi G, Burlina A, Rodriguez Hernandez MA, Chiandetti L, Clementi M, Trevisson E, Navas P, Zuffardi O, Salviati L (2015) Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. Eur J Hum Genet 23:1254\u20131258","journal-title":"Eur J Hum Genet"},{"key":"4093_CR110","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.chembiol.2016.08.008","volume":"23","author":"LA Payet","year":"2016","unstructured":"Payet LA, Leroux M, Willison JC, Kihara A, Pelosi L, Pierrel F (2016) Mechanistic details of early steps in coenzyme Q biosynthesis pathway in yeast. Cell Chem Biol 23:1241\u20131250","journal-title":"Cell Chem Biol"},{"key":"4093_CR111","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.bbabio.2016.03.036","volume":"1857","author":"MJ Acosta","year":"2016","unstructured":"Acosta MJ, Vazquez Fonseca L, Desbats MA, Cerqua C, Zordan R, Trevisson E, Salviati L (2016) Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta 1857:1079\u20131085","journal-title":"Biochim Biophys Acta"},{"key":"4093_CR112","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1056\/NEJMc0800582","volume":"358","author":"G Montini","year":"2008","unstructured":"Montini G, Malaventura C, Salviati L (2008) Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 358:2849\u20132850","journal-title":"N Engl J Med"},{"key":"4093_CR113","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1681\/ASN.2006080833","volume":"18","author":"F Diomedi-Camassei","year":"2007","unstructured":"Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, Caridi G, Piemonte F, Montini G, Ghiggeri GM, Murer L, Barisoni L, Pastore A, Muda AO, Valente ML, Bertini E, Emma F (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18:2773\u20132780","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR114","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00467-013-2482-z","volume":"29","author":"F Ozaltin","year":"2014","unstructured":"Ozaltin F (2014) Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies. Pediatr Nephrol 29:961\u2013969","journal-title":"Pediatr Nephrol"},{"key":"4093_CR115","doi-asserted-by":"publisher","unstructured":"Starr MC, Chang IJ, Finn LS, Sun A, Larson AA, Goebel J, Hanevold C, Thies J, Van Hove JLK, Hingorani SR, Lam C (2018) COQ2 nephropathy: a treatable cause of nephrotic syndrome in children. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-018-3937-z","DOI":"10.1007\/s00467-018-3937-z"},{"key":"4093_CR116","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1172\/JCI69000","volume":"123","author":"S Ashraf","year":"2013","unstructured":"Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschke P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, Kari JA, Evans J, Bierzynska A, Saleem MA, Bockenhauer D, Kleta R, El Desoky S, Hacihamdioglu DO, Gok F, Washburn J, Wiggins RC, Choi M, Lifton RP, Levy S, Han Z, Salviati L, Prokisch H, Williams DS, Pollak M, Clarke CF, Pei Y, Antignac C, Hildebrandt F (2013) ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest 123:5179\u20135189","journal-title":"J Clin Invest"},{"key":"4093_CR117","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1681\/ASN.2011040337","volume":"22","author":"B Ovunc","year":"2011","unstructured":"Ovunc B, Otto EA, Vega-Warner V, Saisawat P, Ashraf S, Ramaswami G, Fathy HM, Schoeb D, Chernin G, Lyons RH, Yilmaz E, Hildebrandt F (2011) Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria. J Am Soc Nephrol 22:1815\u20131820","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR118","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1681\/ASN.2010050492","volume":"21","author":"S Amsellem","year":"2010","unstructured":"Amsellem S, Gburek J, Hamard G, Nielsen R, Willnow TE, Devuyst O, Nexo E, Verroust PJ, Christensen EI, Kozyraki R (2010) Cubilin is essential for albumin reabsorption in the renal proximal tubule. J Am Soc Nephrol 21:1859\u20131867","journal-title":"J Am Soc Nephrol"},{"key":"4093_CR119","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1106215","volume":"308","author":"MP Winn","year":"2005","unstructured":"Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308:1801\u20131804","journal-title":"Science"},{"key":"4093_CR120","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ceca.2012.01.001","volume":"51","author":"N Urban","year":"2012","unstructured":"Urban N, Hill K, Wang L, Kuebler WM, Schaefer M (2012) Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction. Cell Calcium 51:194\u2013206","journal-title":"Cell Calcium"},{"key":"4093_CR121","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1126\/science.aal4178","volume":"358","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Castonguay P, Sidhom EH, Clark AR, Dvela-Levitt M, Kim S, Sieber J, Wieder N, Jung JY, Andreeva S, Reichardt J, Dubois F, Hoffmann SC, Basgen JM, Montesinos MS, Weins A, Johnson AC, Lander ES, Garrett MR, Hopkins CR, Greka A (2017) A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models. Science 358:1332\u20131336","journal-title":"Science"},{"key":"4093_CR122","doi-asserted-by":"crossref","unstructured":"Hall GLB, Khan K, Pediaditakis I, Xiao J, Wu G, Wang L, Kovalik ME, Chryst-Stangl M, Davis EE, Spurney RF, Gbadegesin RA (2018) The human FSGS-causing ANLN R431C mutation induces dysregulated PI3K\/AKT\/mTOR\/Rac1 signaling in podocytes. J Am Soc Nephrol 29:2011\u20132122","DOI":"10.1681\/ASN.2017121338"},{"key":"4093_CR123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00467-003-1314-y","volume":"19","author":"A Bagga","year":"2004","unstructured":"Bagga A, Mudigoudar BD, Hari P, Vasudev V (2004) Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr Nephrol 19:45\u201350","journal-title":"Pediatr Nephrol"},{"key":"4093_CR124","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00467-009-1375-7","volume":"25","author":"Z Li","year":"2010","unstructured":"Li Z, Duan C, He J, Wu T, Xun M, Zhang Y, Yin Y (2010) Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 25:883\u2013888","journal-title":"Pediatr Nephrol"},{"key":"4093_CR125","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/ckj\/sfv090","volume":"8","author":"T Wada","year":"2015","unstructured":"Wada T, Nangaku M (2015) A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues. Clin Kidney J 8:708\u2013715","journal-title":"Clin Kidney J"},{"key":"4093_CR126","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3765608","volume":"2016","author":"E Konigshausen","year":"2016","unstructured":"Konigshausen E, Sellin L (2016) Circulating permeability factors in primary focal segmental glomerulosclerosis: a review of proposed candidates. Biomed Res Int 2016:3765608","journal-title":"Biomed Res Int"},{"key":"4093_CR127","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00467-018-3994-3","volume":"33","author":"JHKK Pelletier","year":"2018","unstructured":"Pelletier JHKK, Engen R, Bensimhon A, Varner J, Rheault M, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer S, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA (2018) Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol 33:1773\u20131780","journal-title":"Pediatr Nephrol"},{"key":"4093_CR128","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0272-6386(99)70435-X","volume":"33","author":"MP Winn","year":"1999","unstructured":"Winn MP, Alkhunaizi AM, Bennett WM, Garber RL, Howell DN, Butterly DW, Conlon PJ (1999) Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis 33:970\u2013974","journal-title":"Am J Kidney Dis"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-4093-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T04:20:02Z","timestamp":1662178802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-4093-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":128,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["4093"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4093-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}